{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:17:07Z","timestamp":1783487827662,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunoglobulin A nephropathy (IgAN) is the most prevalent primary glomerulonephritis worldwide and a leading cause of end-stage renal disease, posing a significant threat to human health. Modified Huangqi Chifeng decoction (MHCD) has shown efficacy in ameliorating IgAN; however, its underlying regulatory mechanisms remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To evaluate the anti-inflammatory and anti-fibrotic effects of MHCD on IgAN and elucidate its molecular mechanisms through\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An IgAN rat model was established. The therapeutic effects of MHCD were assessed by measuring 24-hour urinary protein, Gd-IgA1, serum biochemistry, renal pathological damage, IgA deposition, inflammatory mediators, and fibrosis levels after 8 weeks of MHCD administration. ELISA was used to quantify inflammatory mediators; Western blot and immunohistochemistry were employed to analyze protein expression; PCR was performed to determine miR-146a levels. Subsequently, lipopolysaccharide-stimulated mesangial cells were used\n                      <jats:italic>in vitro<\/jats:italic>\n                      . Mesangial cell proliferation and the expression of TLR4\/NF-\u03baB signaling pathway components and downstream inflammatory factors was examined to verify the anti-inflammatory and anti-fibrotic mechanism of MHCD by overexpressing or silencing miR-146a.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MHCD reduced urinary protein and serum Gd-IgA1 in IgAN rats, and alleviated renal IgA deposition, pathological injury, inflammation and fibrosis. Furthermore, MHCD inhibited renal expression of TLR4, MyD88, NF-\u03baB p65 and NF-\u03baB p-p65, and increased the level of miR-146a. Mechanistically,\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments demonstrated that MHCD exerted anti-inflammatory and anti-fibrotic effects by upregulating miR-146a and inhibiting the TLR4\/NF-\u03baB signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MHCD alleviates IgA nephropathy inflammation and renal fibrosis partially through upregulating miR-146a and subsequently suppressing the TLR4\/NF-\u03baB signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1867439","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:53:42Z","timestamp":1783486422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Modified Huangqi Chifeng decoction alleviates IgA nephropathy inflammation and renal fibrosis via miR-146a\/TLR4\/NF-\u03baB signaling modulation"],"prefix":"10.3389","volume":"17","author":[{"given":"Yue","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Center, Chongqing Academy of Medical Sciences, Chongqing General Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Ma","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Zhejiang Chinese Medical University (Zhongshan Hospital of Zhejiang Province)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangyu","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujie","family":"Shi","sequence":"additional","affiliation":[{"name":"Deparment of Nephrology, The First Hospital of Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Chang","sequence":"additional","affiliation":[{"name":"Deparment of Nephrology, The First Hospital of Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.07420716","article-title":"Iga nephropathy","volume":"12","author":"Rodrigues","year":"2017","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.2174\/1566524054553450","article-title":"Iga nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.01.024","article-title":"Iga nephropathy: Core curriculum 2021","volume":"78","author":"Pattrapornpisut","year":"2021","journal-title":"Am J Kidney Dis: Off J Natl Kidney Foundation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ckj\/sfag146","article-title":"Iga nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1038\/s41467-025-60819-w","article-title":"Lysosome-mediated aggregation of galactose-deficient Iga1 with transferrin receptor 1 links to Iga nephropathy","volume":"16","author":"Si","year":"2025","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2016101103","article-title":"Transcriptomic and proteomic profiling provides insight into mesangial cell function in Iga nephropathy","volume":"28","author":"Liu","year":"2017","journal-title":"J Am Soc Nephrol: JASN"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1751550","article-title":"Paeoniflorin attenuates sepsis-induced liver injury by reprogramming macrophage polarization via the Tlr4\/Nf-Kb pathway","volume":"16","author":"Rong","year":"2025","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.70144","article-title":"Forsythiaside a alleviates kidney injury and intestinal epithelium dysfunction in Iga nephropathy by inhibiting Tlr4\/Nf-Kb signaling","volume":"42","author":"Li","year":"2026","journal-title":"Kaohsiung J Med Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2249.2009.04045.x","article-title":"Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin a nephropathy","volume":"159","author":"Coppo","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr403","article-title":"Tonsillar Tlr9 expression and efficacy of tonsillectomy with steroid pulse therapy in Iga nephropathy patients","volume":"27","author":"Sato","year":"2012","journal-title":"Nephrol Dialysis Transpl: Off Publ Eur Dialysis Transplant Assoc  Eur Renal Assoc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature09267","article-title":"Mammalian micrornas predominantly act to decrease target mrna levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.298.5602.2296","article-title":"Breakthrough of the year. Small rnas make big splash","volume":"298","author":"Couzin","year":"2002","journal-title":"Sci (New York NY)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5597","article-title":"Microrna-146a constrains multiple parameters of intestinal immunity and increases susceptibility to dss colitis","volume":"6","author":"Runtsch","year":"2015","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.761450","article-title":"Epigenetic modulation of class-switch DNA recombination to Iga by mir-146a through downregulation of Smad2, Smad3 and Smad4","volume":"12","author":"Casali","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129733","article-title":"Oral delivery of mir-146a-5p overexpression plasmid-loaded pickering double emulsion modulates intestinal inflammation and the gut microbe","volume":"261","author":"Zhu","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"118318","DOI":"10.2139\/ssrn.4780845","article-title":"Niaodukang mixture inhibits micro-inflammation in ckd rats by enhancing mir-146a levels in enterogenous exosomes","volume":"332","author":"Liu","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17071076","article-title":"Microrna-146a-5p negatively regulates pro-inflammatory cytokine secretion and cell activation in lipopolysaccharide stimulated human hepatic stellate cells through inhibition of toll-like receptor 4 signaling pathways","volume":"17","author":"Chen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156458","article-title":"Polysaccharides from hawthorn fruit alleviate high-fat diet-induced nafld in mice by improving gut microbiota dysbiosis and hepatic metabolic disorder","volume":"139","author":"Zhou","year":"2025","journal-title":"Phytomedicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"200245","DOI":"10.6023\/cjoc202300001","article-title":"Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP\/NLRP3 signaling pathway","volume":"6","author":"Gao","year":"2025","journal-title":"Clin Traditional Med Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2024.200138","article-title":"Protective effects of naringin on fipronil-induced cardiovascular and renal dysfunctions in rats","volume":"5","author":"Ajibade","year":"2024","journal-title":"Clin Traditional Med Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114795","article-title":"Efficacy of modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with Iga nephropathy by inhibiting the Tgf-B1\/Smad3 signaling pathway through exosome regulation","volume":"285","author":"Zhao","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.19852\/j.cnki.jtcm.20240203.001","article-title":"Protective effect of modified Huangqi Chifeng decoction on immunoglobulin a nephropathy through toll-like receptor 4\/myeloid differentiation factor 88\/nuclear factor-kappa B signaling pathway","volume":"44","author":"Liusheng","year":"2024","journal-title":"J Traditional Chin Med = Chung I Tsa Chih Ying Wen Pan"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116220","article-title":"Effects of modified Huangqi Chifeng decoction on the Il-17 signaling pathway in an Iga nephropathy rat model","volume":"307","author":"Ma","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.714584","article-title":"Modified Huangqi Chifeng decoction attenuates proteinuria by reducing podocyte injury in a rat model of immunoglobulin a nephropathy","volume":"12","author":"Chang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117520","article-title":"Ameliorative effects of modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by Pi3k\/Akt\/Mtor and Ampk\/Mtor pathways","volume":"321","author":"Zhao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.13935\/j.cnki.sjzx.160715","article-title":"Effects of modified Huangqi Chifeng decoction on mouse mesangial cell proliferation and extracellular matrix secretion","volume":"11","author":"Jiao","year":"2016","journal-title":"World J Chin Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.0000000000000135","article-title":"Long-term outcomes in Iga nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"B28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.ajkd.2023.12.016","article-title":"Time-varying proteinuria and progression of Iga nephropathy: A cohort study","volume":"84","author":"Tang","year":"2024","journal-title":"Am J Kidney Dis: Off J Natl Kidney Foundation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.01.014","article-title":"Treatment of patients with Iga nephropathy: A call for a new paradigm","volume":"107","author":"Floege","year":"2025","journal-title":"Kidney Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10157-018-1582-2","article-title":"Biomarkers for Iga nephropathy on the basis of multi-hit pathogenesis","volume":"23","author":"Suzuki","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173651","article-title":"Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with Iga nephropathy progression","volume":"9","author":"Chen","year":"2024","journal-title":"JCI Insight"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111065","article-title":"C5a enhances V\u03b41 T cells recruitment via the Ccl2-Ccr2 axis in Iga nephropathy","volume":"125","author":"Deng","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m113.512277","article-title":"Cytokines alter Iga1 O-glycosylation by dysregulating C1galt1 and St6galnac-Ii enzymes","volume":"289","author":"Suzuki","year":"2014","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110289","article-title":"Transforming growth factor-B signaling: From tissue fibrosis to therapeutic opportunities","volume":"369","author":"Ren","year":"2023","journal-title":"Chem Biol Interact"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/imna-d-25-00038","article-title":"Glycolysis-driven renal fibrosis in chronic kidney disease: Emerging mechanisms and therapeutic opportunities","volume":"12","author":"Shao","year":"2025","journal-title":"Integr Med Nephrol Androl"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118693","article-title":"Chlorogenic acid alleviate kidney fibrosis through regulating Tlr4\/Nf-Kb mediated oxidative stress and inflammation","volume":"335","author":"Jiao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01598-4","article-title":"Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting Ahr nuclear translocation in chronic kidney disease","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8324","article-title":"Geniposidic acid attenuates chronic tubulointerstitial nephropathy through regulation of the Nf-Kb\/Nrf2 pathway via aryl hydrocarbon receptor signaling","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2015.10.003","article-title":"Molecular insights into the pathogenesis of Iga nephropathy","volume":"21","author":"Robert","year":"2015","journal-title":"Trends Mol Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0253-7613.150319","article-title":"Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin a nephropathy","volume":"47","author":"Chen","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00832-y","article-title":"Urinary exosomal mir-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis","volume":"34","author":"Perez-Hernandez","year":"2021","journal-title":"J Nephrol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201908_18744","article-title":"Mir-146a relieves kidney injury in mice with systemic lupus erythematosus through regulating Nf-Kb pathway","volume":"23","author":"Fu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8576234","article-title":"Effects and mechanism of Lncrna Crnde on sepsis-induced acute kidney injury","volume":"2020","author":"Wu","year":"2020","journal-title":"Anal Cell Pathol (Amsterdam)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1867439\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:53:59Z","timestamp":1783486439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1867439\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1867439"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1867439","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1867439"}}